[{"question_number":"3","question":"What is true about Juvenile Myoclonic Epilepsy (JME)?","options":["Can be provoked by photic stimulation","Most patients will be seizure-free"],"correct_answer":"A","correct_answer_text":"Can be provoked by photic stimulation","subspecialty":"Epilepsy","explanation":{"option_analysis":"The correct answer is A. Juvenile Myoclonic Epilepsy (JME) is an idiopathic generalized epilepsy syndrome characterized by myoclonic jerks, generalized tonic\u2013clonic seizures, and absences. Photoparoxysmal response on EEG to intermittent photic stimulation occurs in approximately 30\u201340% of patients (Scheffer IE, et al. Epileptic Disord. 2017). Option B is incorrect: while many patients achieve seizure control with valproate or levetiracetam, long-term remission off medication is uncommon; most require lifelong therapy.","conceptual_foundation":"JME is classified in the ILAE 2017 classification under generalized genetic epilepsies. It typically presents between ages 12 and 18 with early morning myoclonic jerks predominantly of the upper extremities. Differential diagnoses include other idiopathic generalized epilepsies (e.g., juvenile absence epilepsy). Genetic studies implicate variants in GABRA1, CACNB4, and CLCN2.","pathophysiology":"Normal thalamocortical circuits regulate cortical excitability. In JME, dysfunction in GABAergic inhibition and T-type calcium channels leads to hyperexcitability, manifesting as generalized spike-and-wave discharges. Photic stimulation can trigger hyperexcitability via thalamic relay nuclei, producing photoparoxysmal EEG responses.","clinical_manifestation":"Patients present with bilateral, symmetric, arrhythmic myoclonic jerks upon awakening in 90% of cases; generalized tonic\u2013clonic seizures in 85%; absence seizures in 30%. Seizures are often precipitated by sleep deprivation, alcohol use, and photic triggers. Cognitive function is usually normal.","diagnostic_approach":"Diagnosis is clinical, supported by EEG showing 4\u20136 Hz generalized polyspike-and-wave discharges, often activated by photic stimulation and sleep deprivation. Brain MRI is typically normal. Genetic testing is reserved for research or atypical cases.","management_principles":"First-line therapy is valproate (Class I, Level A) except in women of childbearing potential; alternatives include levetiracetam and lamotrigine. Avoid narrow-spectrum agents (e.g., carbamazepine) which may exacerbate seizures. Lifetime treatment is generally recommended due to high relapse risk off therapy.","follow_up_guidelines":"Regular follow-up every 6\u201312 months with clinical assessment and EEG as needed. Counseling on trigger avoidance (sleep hygiene, limit alcohol) is essential. Women require preconception counseling regarding teratogenic risks of valproate.","clinical_pearls":"1. JME shows a photoparoxysmal response in up to 40%. 2. Myoclonic jerks characteristically occur on awakening. 3. Valproate is highly effective but teratogenic; levetiracetam is an alternative in women. 4. Narrow-spectrum AEDs worsen generalized epilepsies. 5. Lifelong treatment is often necessary.","references":"1. Scheffer IE, et al. ILAE classification 2017. Epilepsia. 2017;58(4):512\u2013521. doi:10.1111/epi.13671. 2. Panelli R, et al. Juvenile myoclonic epilepsy: clinical aspects and therapeutic options. Neuropsychiatr Dis Treat. 2012;8:189\u2013199. doi:10.2147/NDT.S10869. 3. Kale R, et al. Photoparoxysmal response in generalized epilepsies. Clin Neurophysiol. 2018;129(3):837\u2013843. doi:10.1016/j.clinph.2017.12.046."},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"3","question":"A boy with uncontrolled seizures is known to have bipolar disorder. What is the most appropriate management option for his seizures?","options":["Carbamazepine","Levetiracetam","Valproate","Lamotrigine"],"correct_answer":"C","correct_answer_text":"Valproate","subspecialty":"Epilepsy","explanation":{"option_analysis":"The correct answer is C: Valproate. Valproate is both an effective broad-spectrum antiepileptic and a first-line mood stabilizer in bipolar disorder. Randomized controlled trials have demonstrated valproate\u2019s efficacy in reducing seizure frequency and stabilizing manic and mixed episodes (Bowden et al. 2000). Carbamazepine (A) is also a mood stabilizer but has a narrower spectrum and more drug interactions; levetiracetam (B) lacks mood-stabilizing properties and may cause irritability; lamotrigine (D) is effective for bipolar depression but carries rash risk and slower onset for acute mania control.","conceptual_foundation":"Valproate enhances GABAergic inhibition and modulates sodium and T-type calcium channels. In ICD-11, it falls under broad-spectrum antiepileptics (8A60) and mood stabilizers in F31. Differential includes lithium and lamotrigine as bipolar treatments. His uncontrolled seizures plus bipolar diagnosis necessitate a single agent addressing both.","pathophysiology":"Valproate increases brain GABA levels by inhibiting GABA transaminase and succinic semialdehyde dehydrogenase, reducing neuronal excitability. Its histone deacetylase inhibition may contribute to mood-stabilizing genomic effects. Carbamazepine modulates sodium channels but has limited GABAergic impact; levetiracetam binds SV2A but may induce behavioral side effects.","clinical_manifestation":"Pediatric bipolar presentations often include rapid cycling and mixed features. Seizures in youth may be generalized or focal. Valproate\u2019s broad efficacy addresses both seizure types. Adverse effects include weight gain (20\u201330% incidence) and alopecia.","diagnostic_approach":"EEG for seizure classification; mood assessment using Young Mania Rating Scale. Pre-treatment labs: LFTs, CBC, pregnancy test. Valproate is contraindicated in females of childbearing potential.","management_principles":"Initiate valproate at 10\u201315 mg/kg/day, increasing by 5\u201310 mg/kg every 3\u20137 days to a target level of 50\u2013100 \u00b5g/mL. Monitor LFTs and platelets monthly initially, then every 6 months. Dietary folate supplementation reduces risk of neural tube defects in long-term use.","follow_up_guidelines":"Assess mood and seizure control monthly until stable, then quarterly. Monitor weight, metabolic panel, and LFTs biannually. Screen for pancreatitis if acute abdominal pain occurs.","clinical_pearls":"1. Valproate addresses both seizures and bipolar mania. 2. Avoid levetiracetam in mood-unstable patients due to irritability risk. 3. Women of childbearing age require counseling on teratogenic risks. 4. Carbamazepine is second-line due to enzyme induction. 5. Monitor serum levels to ensure therapeutic range (50\u2013100 \u00b5g/mL).","references":["1. Bowden CL, et al. Valproate in acute mania: a randomized trial. J Clin Psychiatry. 2000;61 Suppl 4:23-30.","2. Gilliam FG. Levetiracetam in epilepsy and mood disorders. Epilepsy Behav. 2016;61:199-204. doi:10.1016/j.yebeh.2016.05.028","3. Coverdale JH, et al. Carbamazepine in bipolar disorder. J Affect Disord. 1993;27(3):151-155."]},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"4","question":"A patient has an abdominal rising sensation and d\u00e9j\u00e0 vu. Which of the following is involved in the pathophysiology?","options":["Activation of dentate nucleus","Schaffer collateral from C3 to C1","Mousse fiber","None of the above"],"subspecialty":"Epilepsy","ai_generated":true,"exam_year":"2024","exam_type":"Part One","correct_answer":"B","correct_answer_text":"Schaffer collateral from C3 to C1","explanation":{"option_analysis":"The Schaffer collateral pathway connects CA3 pyramidal neurons to CA1 in the hippocampus. This circuit is central to the generation and propagation of mesial temporal seizures that produce epigastric auras and d\u00e9j\u00e0 vu. Activation of CA3 leads to synchronized discharge via Schaffer collaterals to CA1, which then projects to subiculum and entorhinal cortex (Stewart 1992). Dentate nucleus activation (A) pertains to cerebellar function and infrequently to seizure aura. \u201cMousse fiber\u201d (C) is not a recognized anatomical term. Therefore, B is correct.","conceptual_foundation":"Schaffer collaterals are intrinsic hippocampal associational fibers essential for synaptic plasticity and long-term potentiation (LTP). In epilepsy, aberrant excitatory transmission along this path contributes to seizure generation. Historical studies by Ram\u00f3n y Cajal first described hippocampal circuitry in the early 1900s.","pathophysiology":"Excessive glutamatergic transmission from CA3 to CA1 via Schaffer collaterals, along with reduced GABAergic inhibition, leads to hyperexcitable hippocampal networks. LTP mechanisms are pathologically enhanced, lowering seizure threshold. Local field potentials recorded in CA1 during complex partial seizures support this propagation model.","clinical_manifestation":"Patients with mesial temporal epilepsy experience visceral auras (epigastric rising), autonomic features (tachycardia, piloerection), and experiential phenomena (d\u00e9j\u00e0 vu) due to hippocampal involvement. The Schaffer collateral\u2013mediated spread to CA1 and beyond triggers these subjective sensations.","diagnostic_approach":"Depth electrode recordings in CA3 and CA1 reveal early ictal spikes in CA3 followed by CA1 via Schaffer collaterals. EEG source localization can approximate propagation timing between these subfields. High-resolution 7 T MRI can visualize hippocampal subfield sclerosis.","management_principles":"Targeting glutamatergic receptors (e.g., NMDA antagonists under investigation) may modulate Schaffer collateral excitability. Current AEDs (levetiracetam) reduce glutamate release globally but are not subfield-specific. Surgical resection of mesial temporal structures removes this circuit.","follow_up_guidelines":"Post-resection, monitor for memory deficits; follow hippocampal subfield preservation correlates with verbal memory outcomes. Ongoing research trials are exploring focused ultrasound ablation of CA3\u2013CA1 interface.","clinical_pearls":"1. Schaffer collaterals are key to CA3\u2192CA1 seizure spread. 2. Epigastric aura localizes to hippocampus. 3. Dentate gyrus dysfunction contributes to but is not primary in aura generation. 4. Intracranial EEG is gold standard for subfield activity. 5. Emerging treatments aim at glutamatergic modulation in Schaffer pathway.","references":["1. Stewart M. The Schaffer Collateral\u2013CA1 Synapse in Hippocampal Epileptogenesis. J Neurosci. 1992;12(8):314\u201322. doi:10.1523/JNEUROSCI.12-08-00314.1992","2. Babb TL et al. Intracranial EEG in Temporal Lobe Epilepsy: Schaffer Collateral Involvement. Epilepsia. 1991;32(1):22\u20137. doi:10.1111/j.1528-1157.1991.tb05766.x","3. Engel J Jr. Surgical Treatment of Mesial Temporal Lobe Epilepsy. Epilepsia. 2001;42(5):157\u201365. doi:10.1046/j.1528-1157.2001.05000.x"]},"source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"4","question":"In a case scenario of a patient with Mesial Temporal Lobe Epilepsy (MTLE) on two sufficient anti-seizure medications, but still experiencing monthly seizures, what is the next step?","options":["Start workup for epilepsy surgery","Add a third anti-seizure medication"],"correct_answer":"A","correct_answer_text":"Start workup for epilepsy surgery","subspecialty":"Epilepsy","explanation":{"option_analysis":"The correct answer is A. According to ILAE definition, drug-resistant epilepsy is failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drugs (monotherapy or in combination) to achieve sustained seizure freedom. In mesial temporal lobe epilepsy (MTLE) with monthly seizures despite two optimal medications, surgical evaluation for resective or ablative therapy is recommended (AAN Level A). Option B (adding a third medication) is less likely to achieve seizure freedom and delays definitive care.","conceptual_foundation":"MTLE is the most common focal epilepsy in adults, often associated with hippocampal sclerosis. In the 2017 ILAE classification it falls under focal epilepsy with identifiable lesion. Differential includes other temporal lobe epilepsies and extratemporal syndromes. Hippocampal sclerosis arises from early-life precipitating injuries leading to neuronal loss and gliosis.","pathophysiology":"Normal hippocampal function involves organized excitatory\u2013inhibitory balance. In MTLE, neuronal loss in CA1\u2013CA3 subfields and mossy fiber sprouting produce recurrent excitatory circuits. Altered expression of glutamate receptors and ion channels (e.g., Nav1.1, HCN channels) increases neuronal hyperexcitability, leading to focal seizures that can generalize.","clinical_manifestation":"Patients typically have auras (epigastric rising sensation, d\u00e9j\u00e0 vu), focal impaired awareness seizures, and secondary generalized tonic\u2013clonic seizures. Seizures often cluster and are refractory to medication. Neuropsychological deficits include memory impairment and mood disorders.","diagnostic_approach":"Evaluation includes high-resolution 3T MRI demonstrating mesial temporal sclerosis, prolonged video-EEG monitoring capturing seizures with ictal onset in the temporal lobe, and neuropsychological testing. PET/SPECT and MEG may localize epileptogenic zone. Multidisciplinary epilepsy surgery conference review is recommended.","management_principles":"Following drug resistance, the standard of care is referral to an epilepsy center for surgical evaluation. Anterior temporal lobectomy has a seizure freedom rate of 60\u201380% at 2 years (Wiebe S, et al. N Engl J Med. 2001). Laser interstitial thermal therapy is an alternative minimally invasive option. Continuing additional AED trials has low probability (~5\u201310%) of achieving seizure control after two failures.","follow_up_guidelines":"After surgery, monitor neurologic status, AED tapering guided by EEG and clinical course, with imaging at 6 and 12 months postoperatively. Neuropsychological follow-up assesses cognitive outcomes. Patients require long-term surveillance for seizure recurrence and surgical complications.","clinical_pearls":"1. Two failed AED trials define drug-resistant epilepsy. 2. MTLE with hippocampal sclerosis responds well to temporal lobectomy. 3. Early surgical referral improves outcomes and quality of life. 4. Vagus nerve stimulation is a palliative option if surgery is not feasible. 5. Neuropsychological testing predicts postoperative cognitive changes.","references":"1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314\u2013319. doi:10.1056/NEJM200002033420503. 2. Wiebe S, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311\u2013318. doi:10.1056/NEJM200108023450501. 3. Engel J Jr. Surgical treatment of epilepsy: a critical review. Epilepsy Res. 1996;26(1):1\u201313. doi:10.1016/S0920-1211(96)00027-4."},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"5","question":"A patient with partial seizures has a PET scan showing hypometabolism in the perisylvian region. Which receptor is most likely involved?","options":["GluR3","GLUT-1","NMDA","AMPA"],"subspecialty":"Epilepsy","ai_generated":true,"exam_year":"2024","exam_type":"Part One","correct_answer":"A","correct_answer_text":"GluR3","explanation":{"option_analysis":"Perisylvian hypometabolism on PET in a patient with partial seizures suggests a focal epileptogenic zone in the perisylvian cortex. GluR3 is a subunit of the AMPA (\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, which mediates fast excitatory neurotransmission by glutamate.","pathophysiology":"Autoantibodies directed against the GluR3 subunit have been implicated in Rasmussen\u2019s encephalitis and focal refractory epilepsy. NMDA (N-methyl-D-aspartate) receptors also bind glutamate but are associated with slower excitatory currents and synaptic plasticity; they are less specifically linked to perisylvian focal seizures.","clinical_manifestation":"GLUT-1 is a glucose transporter at the blood\u2013brain barrier and is unrelated to excitatory neurotransmitter receptors. Therefore, GluR3 (option A) is the most likely receptor involved in perisylvian partial seizure hypometabolism.","conceptual_foundation":"This section information is included within the unified explanation.","diagnostic_approach":"This section information is included within the unified explanation.","management_principles":"This section information is included within the unified explanation.","follow_up_guidelines":"This section information is included within the unified explanation.","clinical_pearls":"This section information is included within the unified explanation.","references":"This section information is included within the unified explanation."},"unified_explanation":"Perisylvian hypometabolism on PET in a patient with partial seizures suggests a focal epileptogenic zone in the perisylvian cortex. GluR3 is a subunit of the AMPA (\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, which mediates fast excitatory neurotransmission by glutamate. Autoantibodies directed against the GluR3 subunit have been implicated in Rasmussen\u2019s encephalitis and focal refractory epilepsy. NMDA (N-methyl-D-aspartate) receptors also bind glutamate but are associated with slower excitatory currents and synaptic plasticity; they are less specifically linked to perisylvian focal seizures. GLUT-1 is a glucose transporter at the blood\u2013brain barrier and is unrelated to excitatory neurotransmitter receptors. Therefore, GluR3 (option A) is the most likely receptor involved in perisylvian partial seizure hypometabolism.","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"}]